Digital PCR Market to Grow at 9.23% through 2030F

Increasing prevalence of chronic diseases is expected to drive Global Digital PCR Market in the forecast period, 2026-2030.

According to TechSci Research report, “Digital PCR Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F”, Global Digital PCR Market was valued at USD 814.56 million in 2024 and is expected to reach USD 1372.62 billion by 2030 with a CAGR of 9.23% during the forecast period. This can be ascribed to the increasing demand for diagnostics centers for infectious diseases, genetic diseases and increasing large population of people suffering from acute and chronic diseases. Similarly, increasing population across the globe, adoption of newly developed technologies, and developing awareness among patient and healthcare providers about new technology, are expected to create lucrative opportunities for the growth of global digital PCR market during the forecast period.

However, several technical limitations such as inability to assess DNA quality, use of carcinogenic chemicals, and the failure to detect target molecules due to low quality of the nucleotide template is the main factor which will hamper the global digital PCR market in the forecast period. Additionally, high cost of digital PCR device and the lack of awareness in emerging countries are expected to hamper the overall market growth.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Digital PCR Market"

Global digital PCR market is segmented into by type, by component, by application, by end user and by region.

Based on application, Oncology is the dominant application segment in the global digital PCR (dPCR) market. This prominence is primarily due to the critical role digital PCR plays in cancer diagnostics, monitoring, and treatment planning. dPCR offers highly sensitive and accurate quantification of genetic mutations, copy number variations, and circulating tumor DNA (ctDNA), which are essential for early cancer detection and tracking minimal residual disease. As precision medicine becomes increasingly central to oncology, dPCR's ability to perform absolute quantification without standard curves makes it ideal for identifying rare mutations and low-abundance targets—key factors in detecting and characterizing tumors. It is also widely used for monitoring treatment response and recurrence, especially through non-invasive liquid biopsy techniques. The growing incidence of cancer worldwide and the rising demand for personalized treatment strategies have further accelerated the adoption of digital PCR in oncology. Additionally, ongoing research and the introduction of new cancer-specific biomarkers have expanded the clinical utility of dPCR. Compared to other segments like infectious diseases or rare diseases, oncology benefits from more established diagnostic workflows, greater R&D funding, and higher clinical demand, securing its leading position in the digital PCR market.

Based on region, Asia-Pacific is the fastest-growing region in the global digital PCR (dPCR) market due to a combination of rising healthcare investments, increasing awareness of advanced diagnostic technologies, and a rapidly expanding patient population. Countries such as China, India, Japan, and South Korea are witnessing significant improvements in healthcare infrastructure, driving demand for precise and reliable molecular diagnostic tools like digital PCR. The high prevalence of infectious diseases, cancer, and genetic disorders in the region has created a growing need for early detection and accurate disease monitoring. Governments are increasingly supporting genomics research and public health initiatives, leading to greater integration of advanced technologies in clinical and research settings. The rise of personalized medicine, supported by regional efforts to develop local biotechnology industries, has fueled the adoption of dPCR across various applications. The presence of a large and genetically diverse population provides a rich base for genomic studies, encouraging local and international collaborations. Cost-effective manufacturing, availability of skilled professionals, and growing investment from global players into Asia-Pacific’s biotech sector further support the region’s rapid growth.

Major companies operating in global digital PCR market are:

·         Bio-Rad Laboratories, Inc.

·         Fluidigm Corporation

·         F. Hoffmann-La Roche AG

·         Merck KGaA

·         QIAGEN N.V.

·         Thermo Fisher Scientific Inc.

·         Genetron Holdings Limited

·         Naveris, Inc.

·         SAGA Diagnostics

·         Precigenome LLC

 
Download Free Sample Report

Customers can also request for 10% free customization on this report. 

“Asia Pacific was expected to register the highest growth in the global digital PCR market on account of increasing prevalence and diagnosis rates of infectious disease in the countries like China and India. Similarly, growing awareness among patient population towards new diagnostics options and availability of advanced digital PCR device in the region, is further expected to support the market growth. Additionally, increasing incidence of different type of cancer and rising metabolic disease treatments are expected to propel the market growth till 2030F” said Mr. Karan Chechi, Research Director of TechSci Research, a research based global management consulting firm.

“Digital PCR Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Type (Droplet Digital PCR, Chip Based Digital PCR, Others), By Component (Systems, Kits and Assays, Reagents and Consumables), By Application (Oncology, Infectious Diseases, Rare Diseases, Reproductive Genetics, Others), By End User (Academic and Research Institutions, Biotechnology & Pharmaceutical Companies, Hospitals and Clinics, Others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of global digital PCR market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global digital PCR market.

 
Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com